Logo image of MCS

MARCUS CORPORATION (MCS) Stock Fundamental Analysis

NYSE:MCS - New York Stock Exchange, Inc. - US5663301068 - Common Stock - Currency: USD

17.42  +0.32 (+1.87%)

After market: 17.35 -0.07 (-0.4%)

Fundamental Rating

3

Taking everything into account, MCS scores 3 out of 10 in our fundamental rating. MCS was compared to 72 industry peers in the Entertainment industry. Both the profitability and financial health of MCS have multiple concerns. MCS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

MCS had negative earnings in the past year.
In the past year MCS had a positive cash flow from operations.
In the past 5 years MCS reported 4 times negative net income.
Of the past 5 years MCS 4 years had a positive operating cash flow.
MCS Yearly Net Income VS EBIT VS OCF VS FCFMCS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M -150M

1.2 Ratios

The Return On Assets of MCS (-1.25%) is better than 62.50% of its industry peers.
With a decent Return On Equity value of -2.88%, MCS is doing good in the industry, outperforming 65.28% of the companies in the same industry.
With a decent Return On Invested Capital value of 1.39%, MCS is doing good in the industry, outperforming 63.89% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for MCS is significantly below the industry average of 22.90%.
Industry RankSector Rank
ROA -1.25%
ROE -2.88%
ROIC 1.39%
ROA(3y)-0.16%
ROA(5y)-2.82%
ROE(3y)-0.39%
ROE(5y)-7.15%
ROIC(3y)1.74%
ROIC(5y)N/A
MCS Yearly ROA, ROE, ROICMCS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

MCS has a better Operating Margin (2.39%) than 65.28% of its industry peers.
MCS's Operating Margin has declined in the last couple of years.
MCS has a Gross Margin of 38.67%. This is comparable to the rest of the industry: MCS outperforms 41.67% of its industry peers.
In the last couple of years the Gross Margin of MCS has remained more or less at the same level.
Industry RankSector Rank
OM 2.39%
PM (TTM) N/A
GM 38.67%
OM growth 3YN/A
OM growth 5Y-18.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.54%
MCS Yearly Profit, Operating, Gross MarginsMCS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MCS is destroying value.
The number of shares outstanding for MCS has been reduced compared to 1 year ago.
MCS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, MCS has an improved debt to assets ratio.
MCS Yearly Shares OutstandingMCS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MCS Yearly Total Debt VS Total AssetsMCS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 1.60, we must say that MCS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.60, MCS perfoms like the industry average, outperforming 54.17% of the companies in the same industry.
A Debt/Equity ratio of 0.45 indicates that MCS is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.45, MCS perfoms like the industry average, outperforming 48.61% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 1.6
ROIC/WACC0.18
WACC7.59%
MCS Yearly LT Debt VS Equity VS FCFMCS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.42 indicates that MCS may have some problems paying its short term obligations.
MCS has a worse Current ratio (0.42) than 84.72% of its industry peers.
A Quick Ratio of 0.42 indicates that MCS may have some problems paying its short term obligations.
With a Quick ratio value of 0.42, MCS is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.42
MCS Yearly Current Assets VS Current LiabilitesMCS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

The earnings per share for MCS have decreased strongly by -282.61% in the last year.
MCS shows a small growth in Revenue. In the last year, the Revenue has grown by 4.18%.
The Revenue has been decreasing by -2.17% on average over the past years.
EPS 1Y (TTM)-282.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-42.11%
Revenue 1Y (TTM)4.18%
Revenue growth 3Y17.09%
Revenue growth 5Y-2.17%
Sales Q2Q%7.38%

3.2 Future

Based on estimates for the next years, MCS will show a very strong growth in Earnings Per Share. The EPS will grow by 69.10% on average per year.
MCS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.05% yearly.
EPS Next Y273.51%
EPS Next 2Y114.54%
EPS Next 3Y69.1%
EPS Next 5YN/A
Revenue Next Year6.49%
Revenue Next 2Y5.35%
Revenue Next 3Y4.05%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MCS Yearly Revenue VS EstimatesMCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
MCS Yearly EPS VS EstimatesMCS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MCS. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 25.74 indicates a quite expensive valuation of MCS.
Based on the Price/Forward Earnings ratio, MCS is valued a bit cheaper than the industry average as 70.83% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.90, MCS is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 25.74
MCS Price Earnings VS Forward Price EarningsMCS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

MCS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MCS is cheaper than 84.72% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.5
MCS Per share dataMCS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

MCS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MCS's earnings are expected to grow with 69.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y114.54%
EPS Next 3Y69.1%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.61%, MCS has a reasonable but not impressive dividend return.
MCS's Dividend Yield is rather good when compared to the industry average which is at 6.60. MCS pays more dividend than 88.89% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 2.38, MCS is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.61%

5.2 History

The dividend of MCS decreases each year by -13.79%.
MCS has been paying a dividend for at least 10 years, so it has a reliable track record.
MCS has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-13.79%
Div Incr Years2
Div Non Decr Years2
MCS Yearly Dividends per shareMCS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

MCS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-68.74%
EPS Next 2Y114.54%
EPS Next 3Y69.1%
MCS Yearly Income VS Free CF VS DividendMCS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

MARCUS CORPORATION

NYSE:MCS (7/3/2025, 7:47:18 PM)

After market: 17.35 -0.07 (-0.4%)

17.42

+0.32 (+1.87%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners79.45%
Inst Owner Change-54.43%
Ins Owners5.01%
Ins Owner Change5.16%
Market Cap545.25M
Analysts82.5
Price Target25.76 (47.88%)
Short Float %2.88%
Short Ratio3.86
Dividend
Industry RankSector Rank
Dividend Yield 1.61%
Yearly Dividend0.28
Dividend Growth(5Y)-13.79%
DP-68.74%
Div Incr Years2
Div Non Decr Years2
Ex-Date05-27 2025-05-27 (0.07)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-41.62%
Min EPS beat(2)-73%
Max EPS beat(2)-10.24%
EPS beat(4)1
Avg EPS beat(4)-665.19%
Min EPS beat(4)-2634.65%
Max EPS beat(4)57.12%
EPS beat(8)3
Avg EPS beat(8)-322.39%
EPS beat(12)5
Avg EPS beat(12)-206.41%
EPS beat(16)8
Avg EPS beat(16)-135.95%
Revenue beat(2)2
Avg Revenue beat(2)3.59%
Min Revenue beat(2)1.88%
Max Revenue beat(2)5.29%
Revenue beat(4)4
Avg Revenue beat(4)5.54%
Min Revenue beat(4)1.88%
Max Revenue beat(4)8.6%
Revenue beat(8)7
Avg Revenue beat(8)3.58%
Revenue beat(12)11
Avg Revenue beat(12)4.64%
Revenue beat(16)15
Avg Revenue beat(16)7.84%
PT rev (1m)-1.62%
PT rev (3m)-4.11%
EPS NQ rev (1m)-17.04%
EPS NQ rev (3m)273.34%
EPS NY rev (1m)-6.94%
EPS NY rev (3m)11.67%
Revenue NQ rev (1m)-1.1%
Revenue NQ rev (3m)0.92%
Revenue NY rev (1m)-0.33%
Revenue NY rev (3m)1.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 25.74
P/S 0.73
P/FCF N/A
P/OCF 6.51
P/B 1.23
P/tB 1.49
EV/EBITDA 8.5
EPS(TTM)-0.42
EYN/A
EPS(NY)0.68
Fwd EY3.88%
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)2.67
OCFY15.35%
SpS23.83
BVpS14.11
TBVpS11.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.25%
ROE -2.88%
ROCE 2.04%
ROIC 1.39%
ROICexc 1.41%
ROICexgc 1.55%
OM 2.39%
PM (TTM) N/A
GM 38.67%
FCFM N/A
ROA(3y)-0.16%
ROA(5y)-2.82%
ROE(3y)-0.39%
ROE(5y)-7.15%
ROIC(3y)1.74%
ROIC(5y)N/A
ROICexc(3y)1.83%
ROICexc(5y)N/A
ROICexgc(3y)2.03%
ROICexgc(5y)N/A
ROCE(3y)2.54%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-14.17%
ROICexc growth 3YN/A
ROICexc growth 5Y-14.65%
OM growth 3YN/A
OM growth 5Y-18.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.54%
F-Score4
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA 2.27
Cap/Depr 124.35%
Cap/Sales 11.64%
Interest Coverage 2.14
Cash Conversion 95.52%
Profit Quality N/A
Current Ratio 0.42
Quick Ratio 0.42
Altman-Z 1.6
F-Score4
WACC7.59%
ROIC/WACC0.18
Cap/Depr(3y)76.34%
Cap/Depr(5y)56.25%
Cap/Sales(3y)7.17%
Cap/Sales(5y)6.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-282.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-42.11%
EPS Next Y273.51%
EPS Next 2Y114.54%
EPS Next 3Y69.1%
EPS Next 5YN/A
Revenue 1Y (TTM)4.18%
Revenue growth 3Y17.09%
Revenue growth 5Y-2.17%
Sales Q2Q%7.38%
Revenue Next Year6.49%
Revenue Next 2Y5.35%
Revenue Next 3Y4.05%
Revenue Next 5YN/A
EBIT growth 1Y-34.6%
EBIT growth 3YN/A
EBIT growth 5Y-20.28%
EBIT Next Year325.97%
EBIT Next 3Y68.8%
EBIT Next 5YN/A
FCF growth 1Y-107.68%
FCF growth 3Y-5.39%
FCF growth 5Y-20.4%
OCF growth 1Y5.96%
OCF growth 3Y30.94%
OCF growth 5Y-5.98%